News

New allotment space for Whitley residents

28 April 2022

Tunstall Healthcare has partnered with Whitley Parish Council to improve the community area of the local allotments which provide Whitley residents with opportunities to grow healthy, fresh food while benefiting from fresh air and exercise.

Tunstall announces new Group CEO as it looks to the future

11 April 2022

Global market leading health and care technology company, Tunstall Healthcare, has announced the appointment of Emil Peters as group CEO with effect from 16 May 2022.

Tunstall Healthcare launches new telecare device to offer improved support and increase TEC services’ efficiency

07 March 2022

Tunstall Healthcare, has further expanded its product portfolio with the launch of Sound Boost. The revolutionary new product extends the audio range of Tunstall’s Lifeline home alarm units, which are installed in the property of vulnerable individuals to provide 24 hour support. Sound Boost is a telecare device that wirelessly connects to the Lifeline, providing extra audio coverage throughout the home to enable clearer communication between the end user and the monitoring centre.

Tunstall Healthcare, a Global digital health solutions provider, strengthens its position in the German Home care / Telecare market

01 March 2022

UK based, leading global provider of software solutions, services and technology for the telecare and telehealth markets, Tunstall Healthcare, has expanded its German presence and service offering with the acquisition of BeWo Unternehmensgruppe (BeWo) for an undisclosed fee.

A groundbreaking telehealth pilot: What can we learn?

24 February 2022

The results of a new telehealth pilot in Ireland have been launched. Based in County Wexford, the project was undertaken by a multi-agency Stakeholder Group (Wexford County Council-Age Friendly Programme including the Wexford Older People’s Council, Age Friendly Ireland, HSE, Wexford General Hospital). It provided a 12 week telehealth intervention to 50 patients with chronic illnesses including Chronic Heart Disease, COPD & Diabetes and was independently evaluated and monitored by Waterford Institute of Technology.